DCF — TEXAS HEALTH H-E-B
Enterprise Value: $-20.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-20.2M
Enterprise Value
$-13.9M
PV of Cash Flows
$-6.3M
PV of Terminal Value
$-10.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $300.0M | $5.3M | 2.0% | $-7.4M | $-6.7M |
| Year 2 | $309.0M | $8.6M | 3.0% | $-4.7M | $-3.9M |
| Year 3 | $318.3M | $12.0M | 4.0% | $-2.5M | $-1.9M |
| Year 4 | $327.8M | $14.0M | 4.0% | $-1.3M | $-0.9M |
| Year 5 | $337.7M | $15.3M | 5.0% | $-0.7M | $-0.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-20.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$291.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.012682969671748043
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5